These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9293264)

  • 21. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.
    Masri GD; Clark WH; Guerry D; Halpern A; Thompson CJ; Elder DE
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1042-8. PubMed ID: 2370329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma precursors in children.
    Lefkowitz A; Schwartz RA; Janniger CK
    Cutis; 1999 Jun; 63(6):321-4. PubMed ID: 10388950
    [No Abstract]   [Full Text] [Related]  

  • 23. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
    Lindelöf B; Hedblad MA; Sigurgeirsson B
    Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocytic naevi, melanoma and sun exposure.
    Augustsson A
    Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dysplastic pigmented nevi as a high risk group for the development of malignant melanoma].
    Kik A; Kowalewska Z; Pawińska M
    Przegl Dermatol; 1986; 73(4):323-6. PubMed ID: 3333866
    [No Abstract]   [Full Text] [Related]  

  • 27. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.
    Rhodes AR
    Med Clin North Am; 1986 Jan; 70(1):3-37. PubMed ID: 3510347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
    Maor D; Vajdic CM; Cumming S; Fahey V; Bala HR; Snaidr V; Brennand S; Goh MSY; Chong AH
    J Am Acad Dermatol; 2020 Sep; 83(3):773-779. PubMed ID: 31706934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nevi, sun and the risk of melanoma].
    Snellman E; Koulu L; Rantanen T
    Duodecim; 2002; 118(4):359-66; quiz 366, 401. PubMed ID: 12233040
    [No Abstract]   [Full Text] [Related]  

  • 31. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
    Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
    Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign melanocytic naevi as a risk factor for malignant melanoma.
    Swerdlow AJ; English J; MacKie RM; O'Doherty CJ; Hunter JA; Clark J; Hole DJ
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1555-9. PubMed ID: 3087514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle.
    Karlsson P; Stenberg B; Rosdahl I
    Acta Derm Venereol; 2000; 80(5):335-9. PubMed ID: 11200829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
    Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
    JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic mimics of malignant melanoma.
    Bsirini C; Smoller BR
    Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
    Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
    JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups.
    MacKie RM; McHenry P; Hole D
    Lancet; 1993 Jun; 341(8861):1618-20. PubMed ID: 8099990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
    Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
    Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cohort study of melanoma in patients with dysplastic nevi.
    Halpern AC; Guerry D; Elder DE; Trock B; Synnestvedt M
    J Invest Dermatol; 1993 Mar; 100(3):346S-349S. PubMed ID: 8440922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysplastic (atypical) nevi: significance and management.
    Lober CW
    South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.